Twelve creative and influential oncology research leaders are the winners of the 2017 Giants of Cancer Care® awards, a unique honor that recognizes physician-scientists who have helped move cancer care forward.
Twelve creative and influential oncology research leaders are the winners of the 2017 Giants of Cancer Care® awards, a unique honor that recognizes physician-scientists who have helped move cancer care forward. This year’s honorees bring the total number of luminaries who have been chosen for the awards program, now in its fifth year, to 62. The awards are scheduled to be bestowed during a reception held at the Chicago History Museum in Chicago on June 1.
The 2017 recipients were chosen from a field of more than 300 US and international nominees; winners were determined by an elite group of oncologists and hematologists. Here are the recipients of the 2017 Giants of Cancer Care® awards and the categories in which they are being honored:
“The nominees are a very diverse group whose professional achievements range from basic scientists to people who have fought the battle against cancer in underserved areas,” said Patrick I. Borgen, MD, chair of the 2017 Advisory Board of the Giants of Cancer Care®. “There is such a broad spectrum represented in this year’s group.”
Borgen is chairman of the Department of Surgery and director of the Brooklyn Breast Cancer Program at Maimonides Medical Center in Brooklyn, New York. He also serves as the program chair for the Miami Breast Cancer Conference®, one of the nation’s largest breast cancer meetings, which Physicians’ Education Resource® (PER®) hosts annually in Miami Beach, Florida.
The successes in the fight against cancer can be marked in the tireless hours spent at the laboratory bench and in translating that knowledge into treatment strategies that have helped countless patients live longer lives with a better quality of life. This year’s Giants of Cancer Care® award winners have made major contributions to the discovery of novel therapeutics, advances in genomic medicine, and the development of checkpoint blockade immunotherapies.
Maurie Markman, MD, chair of the Advisory Board in 2016, celebrated the tenacity of the nominees. He said the “pioneering efforts, insights, persistence, and leadership of the current class challenges current thinking, wisdom, beliefs, dogma—or the all-too-often claim that ‘it will never work’—to rapidly move the understanding of biology and clinical care forward for the direct bene t of current and future patients.”
The nominations for this year’s campaign kicked off during the 34th Annual CFSTM Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® conference that PER® hosted in New York City in November 2016 and closed in March 2017. During the review process, the Advisory Board culled through the nominations to narrow the field to 71 candidates.
A Selection Committee comprising 93 oncologists and hematologists then voted on each candidate, considering each finalist’s body of work, including clinical impact, significant contributions, and overall accomplishments.
Initially launched by OncLive® in 2013, the Giants of Cancer Care® program honors individuals who have contributed to the advancement in the understanding of cancer and the treatment of patients. Recipients demonstrate the qualities that distinguish this award from others: unlimited selflessness, compassion for their patients, and a desire to understand and develop life-changing treatments against a disease that affects so many.
National Surgical Adjuvant Breast and
Norman Wolmark, MD, chairman, NSABP Foundation.
Bowel Project (NSABP)/NRG Oncology
Charles S. Fuchs, MD, MPH, is the Richard Sackler and Jonathan Sackler Professor of Medicine (Medical Oncology) and director of the Yale Cancer Center and physician-in-chief at Smilow Cancer Hospital.
Yale Cancer Center/Smilow Cancer Hospital
Daniel P. Petrylak, MD, is professor of medicine (medical oncology) and professor of urology at Yale School of Medicine and co-director of the Signal Transduction Research Program at Yale Cancer Center.
Yale University School of Medicine
North Shore University Hospital — LIJ/
Kanti R. Rai, MD, is professor of medicine at The Karches Center for Oncology Research, The Feinstein Institute for Medical Research; director of the Center for Oncology and Cell Biology, Long Island Jewish Medical Center; and professor of medicine and molecular medicine at Hofstra University Northwell School of Medicine.
The Feinstein Institute for Medical Research
Thomas F. Gajewski, MD, PhD, is professor of medicine and pathology at The University of Chicago Medicine.
University of Chicago Medicine
David R. Gandara, MD, is the director of the Thoracic Oncology Program, professor of medicine, and senior adviser to the director at the University of California Davis Comprehensive Cancer Center (UCDCCC).
University of California, Davis
John M. Kirkwood, MD, is the Usher Professor of Medicine, Dermatology & Translational Science and director of the Melanoma and Skin Cancer Program, University of Pittsburgh School of Medicine.
University of Pittsburgh School of Medicine
Joseph V. Simone, MD, is the clinical director emeritus, Huntsman Cancer Institute, and professor emeritus of pediatrics and medicine at the University of Utah School of Medicine.
(retired) Huntsman Cancer Institute
Herman D. Suit, MD, MSc, PhD, is the Andres Soriano Professor of Radiation Oncology, Emeritus, at Harvard Medical School, and chief of radiation oncology at Massachusetts General Hospital.
Harvard Medical School/Massachusetts General Hospital
Sandra and Edward Meyer Cancer Center
Lewis C. Cantley, PhD, is the director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College/Ronald P. Stanton Clinical Cancer Program at New York-Presbyterian, and professor of cancer biology in medicine.
at Weill Cornell Medical College
University of North Carolina
Hyman B. Muss, MD, is a professor of medicine at the University of North Carolina- Chapel Hill School of Medicine and Breast Cancer Geriatric Oncology Program, and director of geriatric oncology at the Lineberger Comprehensive Cancer Center.
Lineberger Comprehensive Cancer Center
John L. Cameron, MD, is the Alfred Blalock Distinguished Service Professor of Surgery, professor of surgery, and professor of oncology at Johns Hopkins University School of Medicine.
Johns Hopkins University School of Medicine
This dynamic program has laid the groundwork for future development and expansion, honoring not only the oncology trailblazers of today, but also cultivating the aspirations of a new generation who are the potential Giants of Cancer Care® candidates in years to come.